NCT06325423View on ClinicalTrials.gov

Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2027

Conditions
Muscle-Invasive Bladder Carcinoma
Interventions
COMBINATION_PRODUCT

neoadjuvant chemotherapy

platinum-based chemotherapy before radical cystectomy or bladder preservation

All Listed Sponsors
lead

Assiut University

OTHER

NCT06325423 - Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer | Biotech Hunter | Biotech Hunter